GEODE CAPITAL MANAGEMENT, LLC - KIORA PHARMACEUTICALS INC ownership

KIORA PHARMACEUTICALS INC's ticker is and the CUSIP is 49721T101. A total of 17 filers reported holding KIORA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of KIORA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$257,000
-21.9%
547,128
+3.3%
0.00%
Q1 2022$329,000
-58.4%
529,764
+1.1%
0.00%
Q4 2021$791,000523,9540.00%
Other shareholders
KIORA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 12,558$6,0000.00%
Renaissance Technologies 41,835$20,0000.00%
VANGUARD GROUP INC 67,212$31,0000.00%
ALBION FINANCIAL GROUP /UT 254$00.00%
UBS Group AG 28,856$13,0000.00%
OSAIC HOLDINGS, INC. 1,468$00.00%
US BANCORP \DE\ 2,710$1,0000.00%
WELLS FARGO & COMPANY/MN 85$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 547,128$257,0000.00%
View complete list of KIORA PHARMACEUTICALS INC shareholders